Multiple Myeloma Includes Phenotypically Defined Subsets of Clonotypic CD20+ B Cells that Persist during Treatment with Rituximab
Potential progenitor B cell compartments in multiple myeloma (MM) are clinically important.MM B cells and some circulating MM plasma cells express CD20, predicting their clearance by treatment with anti-CD20.Here we describe two types of clonotypic CD20+ B cell in peripheral blood Ski de fond - Enfant - Skis - Skate of myeloma patients, identified